JAK-STAT is an international peer-reviewed journal focused on the Janus kinase (JAK) and signal transducer and activator of transcription (STAT) signaling pathways. This pathway is vital for immune responses, cell growth, and differentiation, making the journal relevant to researchers in immunology, oncology, and cell biology. The concise summary of its focus is: Explores the JAK-STAT signaling pathways, critical for immunity, cell growth, and cancer research.
Published by Taylor & Francis, JAK-STAT covers a broad spectrum of topics, including cytokine signaling, receptor biology, transcriptional regulation, and the development of novel therapeutics targeting these pathways. The journal features original research articles, reviews, and perspectives, providing a comprehensive overview of the latest advancements in the field. It is indexed in major databases, including PubMed, Scopus, and Web of Science. This journal attracts a global audience of researchers, clinicians, and industry professionals interested in the JAK-STAT signaling pathway and its implications for human health.
JAK-STAT encourages submissions that explore the therapeutic potential of targeting these pathways in various diseases. As an open-access journal, it ensures that published research is freely accessible to the global scientific community, maximizing its impact and reach. For researchers looking to publish cutting-edge findings in this area, JAK-STAT offers a valuable platform for disseminating their work.